SEC 13F Intelligence

Bml Capital Management, LLC / ADVMCHF

Bml Capital Management, LLC’s Adverum Biotechnologies Inc Position

Does Bml Capital Management, LLC own Adverum Biotechnologies Inc (ADVMCHF)? Not currently — the last reported position was 4.55M shares worth $3M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q4 2023
Shares
4.55M
% of Portfolio
+2.60%
Quarters Held
5
position exited

Position History ADVMCHF

Reported value by quarter
Q4 ’22: $4MQ4 ’22Q1 ’23: $5MQ1 ’23Q2 ’23: $8MQ2 ’23Q3 ’23: $6MQ3 ’23Q4 ’23: $3MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20234.55M$3M+2.60%
Q3 20233.92M$6M+5.39%
Q2 20235.16M$8M+7.38%
Q1 20237.07M$5M+4.38%
Q4 20227.07M$4M+3.91%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bml Capital Management, LLC’s full portfolio or all institutional holders of ADVMCHF.